- NCIt
- C4804
Loading cancer entity…
Loading cancer entity…
Clinical trials
21 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03505372 | Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia | terminated | N/A | 5 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 11, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Feb 11, 2020source: clinicaltrials